Developmental toxicity of meglumine antimoniate and transplacental transfer of antimony in the rat

Reproductive Toxicology

Volumn 21, Issue 3, 2006, Pages 292-300

  Miranda, Elaine S ^a   Miekeley, Norbert ^b   De Carvalho, Rosangela R ^a   Paumgartten, Francisco J R ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Embryotoxicity; Leishmaniasis; Meglumine antimoniate; Pentavalent antimony; Sb kinetics

Indexed keywords

ALIZARIN RED S; ANTIMONY; MEGLUMINE ANTIMONATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; EMBRYOTOXICITY; FEMALE; FETOTOXICITY; FETUS; FETUS WEIGHT; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY; RAT; SOFT TISSUE;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTIMONY; ANTIPROTOZOAL AGENTS; BONE AND BONES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETAL BLOOD; FETAL DEATH; FETAL DEVELOPMENT; FETAL WEIGHT; MATERNAL-FETAL EXCHANGE; MEGLUMINE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGANOMETALLIC COMPOUNDS; PLACENTA; PREGNANCY; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33644501467     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2005.09.010     Document Type: Article

References (17)

1. G.O. Vianna Tratamento da leishmaniose pelo tártaro emético Anais do VII Congresso Brasileiro de Medicina e Cirurgia 4 1912 426 428
2. J.D. Berman Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies Rev Infect Dis 10 1988 560 586
3. P.J. Guerin, P. Olliaro, S. Sundar, M. Boelaert, S.L. Croft, and P. Desjeux Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda Lancet Infect Dis 2 2002 494 501
4. E.A. Figueiro-Filho, G. Duarte, P. El-Beitune, S.M. Quintana, and T.L. Maia Visceral leishmaniasis (kala-azar) and pregnancy Infect Dis Obstet Gynecol 12 2004 31 40
5. F.J.R. Paumgartten, and I. Chahoud Embryotoxicity of meglumine antimoniate in the rat Reprod Toxicol 15 2001 327 331
6. A.M. Alkhawajah, S. Jain, and E.B. Larbi Effects of antimony compounds on foetal development in rats J Appl Animal Res 10 1996 15 24
7. P. Massip, Goutner Ch, Y. Dupic, and P. Navarrot Kala-azar chez la femme enceinte Presse Med 15 1986 933
8. R. Utili, A. Rambaldi, M.F. Tripodi, and A. Andreana Visceral leishmaniasis during pregnancy treated with meglumine antimoniate Infection 23 1995 182 183
9. B.P. Silveira, J. Araujo Sobrinho, L.F. Leite, M.N. Sales, M.S. Gouveia, and R.L. Mathias Nascimento prematuro após o uso de antimonial pentavalente: Relato de caso Rev Soc Bras Med Trop 36 2003 523 525
10. E. Salewski Färbemethoden zum makrokospischen Nachweis von Implantationsstellem am Uterus der Ratte Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 281 1964 367
11. H. Sterz Routine examination of rat and rabbit fetuses for malformations of internal organs: combination of Barrow's and Wilson's methods D. Neubert H.-J. Merker T.E. Kwasigroch Methods in prenatal toxicology 1977 Georg-Thieme Publishers Stuttgart 113 122
12. A.B. Dawson A note on the staining of the skeleton of cleared specimens with Alizarin Red S Stain Technol 1 1926 123 124
13. N. Miekeley, S.R. Mortari, and A.O. Schubach Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated with leishmaniasis Anal Bioanal Chem 372 2002 495 502
14. I. Chahoud, J. Buschmann, R. Clark, and A. Druga Classification terms in developmental toxicology: need for harmonisation Report of the second workshop on the terminology in developmental toxicology Berlin, 27-28 August 1998 Reprod. Toxicol 13 1999 77 82
15. J.D. Chulay, L. Fleckenstein, and D.H. Smith Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate Trans R Soc Trop Med Hyg 82 1988 69 72
16. J.E. Valladares, J. Alberola, M. Esteban, and M. Arboix Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs Vet Rec 138 1996 181 183
17. F. Frézard, C. Demicheli, C.S. Ferreira, and M.A.P. Costa Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate Antimicrob Agents Chemother 45 2001 913 916